Artificial Cells Nanomedicine And Biotechnology SCIE

國際簡稱：ARTIF CELL NANOMED B 參考譯名：人工細(xì)胞納米醫(yī)學(xué)與生物技術(shù)

主要研究方向：ENGINEERING, BIOMEDICAL-BIOTECHNOLOGY & APPLIED MICROBIOLOGY 預(yù)警期刊審稿周期： 20 Weeks

《人工細(xì)胞納米醫(yī)學(xué)與生物技術(shù)》(Artificial Cells Nanomedicine And Biotechnology)是一本由Informa Healthcare出版的以ENGINEERING, BIOMEDICAL-BIOTECHNOLOGY & APPLIED MICROBIOLOGY為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開放期刊。

3區(qū) 中科院分區(qū)
Q1 JCR分區(qū)
53 年發(fā)文量
4.5 IF影響因子
未開放 是否OA
35 H-index
2013 創(chuàng)刊年份
1 issue/year 出版周期
English 出版語言

Artificial Cells, Nanomedicine and Biotechnology covers the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers, stem cells and tissue engineering. Emphasis is on basic research, applied research, and clinical and industrial applications of the following topics:artificial cellsblood substitutes and oxygen therapeuticsnanotechnology, nanobiotecnology, nanomedicinetissue engineeringstem cellsbioencapsulationmicroencapsulation and nanoencapsulationmicroparticles and nanoparticlesliposomescell therapy and gene therapyenzyme therapydrug delivery systemsbiodegradable and biocompatible polymers for scaffolds and carriersbiosensorsimmobilized enzymes and their usesother biotechnological and nanobiotechnological approachesRapid progress in modern research cannot be carried out in isolation and is based on the combined use of the different novel approaches. The interdisciplinary research involving novel approaches, as discussed above, has revolutionized this field resulting in rapid developments. This journal serves to bring these different, modern and futuristic approaches together for the academic, clinical and industrial communities to allow for even greater developments of this highly interdisciplinary area.

[ 查看全部 ]

投稿咨詢加急咨詢

Artificial Cells Nanomedicine And Biotechnology期刊信息

ISSN：2169-1401
出版語言：English
是否OA：未開放
E-ISSN：2169-141X
出版地區(qū)：UNITED STATES
是否預(yù)警：是
出版商：Informa Healthcare
出版周期：1 issue/year
創(chuàng)刊時間：2013
開源占比：0.9865
Gold OA文章占比：98.61%
OA被引用占比：0.4587...
出版國人文章占比：0.46
出版撤稿占比：0.1759...
研究類文章占比：90.57%

Artificial Cells Nanomedicine And Biotechnology CiteScore評價數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

10.9

0.646

0.903

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Medicine (miscellaneous)	Q1	29 / 398	92%
大類：Medicine 小類：Pharmaceutical Science	Q1	14 / 183	92%
大類：Medicine 小類：Biomedical Engineering	Q1	36 / 303	88%
大類：Medicine 小類：Biotechnology	Q1	40 / 311	87%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標(biāo)。當(dāng)年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。

Artificial Cells Nanomedicine And Biotechnology中科院評價數(shù)據(jù)

中科院 2023年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	生物學(xué)	3區(qū)	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程與應(yīng)用微生物 ENGINEERING, BIOMEDICAL 工程：生物醫(yī)學(xué) MATERIALS SCIENCE, BIOMATERIALS 材料科學(xué)：生物材料	3區(qū) 3區(qū) 4區(qū)

中科院 2022年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	工程技術(shù)	2區(qū)	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程與應(yīng)用微生物 ENGINEERING, BIOMEDICAL 工程：生物醫(yī)學(xué) MATERIALS SCIENCE, BIOMATERIALS 材料科學(xué)：生物材料	2區(qū) 2區(qū) 2區(qū)

中科院 2021年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	工程技術(shù)	2區(qū)	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程與應(yīng)用微生物 ENGINEERING, BIOMEDICAL 工程：生物醫(yī)學(xué) MATERIALS SCIENCE, BIOMATERIALS 材料科學(xué)：生物材料	2區(qū) 3區(qū) 3區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	2區(qū)	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程與應(yīng)用微生物 ENGINEERING, BIOMEDICAL 工程：生物醫(yī)學(xué) MATERIALS SCIENCE, BIOMATERIALS 材料科學(xué)：生物材料	2區(qū) 2區(qū) 3區(qū)

中科院 2021年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	工程技術(shù)	2區(qū)	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程與應(yīng)用微生物 ENGINEERING, BIOMEDICAL 工程：生物醫(yī)學(xué) MATERIALS SCIENCE, BIOMATERIALS 材料科學(xué)：生物材料	2區(qū) 3區(qū) 3區(qū)

中科院 2020年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	工程技術(shù)	3區(qū)	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程與應(yīng)用微生物 ENGINEERING, BIOMEDICAL 工程：生物醫(yī)學(xué) MATERIALS SCIENCE, BIOMATERIALS 材料科學(xué)：生物材料	3區(qū) 4區(qū) 4區(qū)

Artificial Cells Nanomedicine And Biotechnology JCR評價數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q1	34 / 174	80.7%
學(xué)科：ENGINEERING, BIOMEDICAL	SCIE	Q2	35 / 122	71.7%
學(xué)科：MATERIALS SCIENCE, BIOMATERIALS	SCIE	Q2	22 / 53	59.4%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q1	34 / 174	80.75%
學(xué)科：ENGINEERING, BIOMEDICAL	SCIE	Q2	31 / 122	75%
學(xué)科：MATERIALS SCIENCE, BIOMATERIALS	SCIE	Q2	14 / 53	74.53%

Artificial Cells Nanomedicine And Biotechnology歷年數(shù)據(jù)統(tǒng)計

影響因子

中科院分區(qū)

Artificial Cells Nanomedicine And Biotechnology中國學(xué)者發(fā)文選摘

1、The Rhei radix rhizoma-based carbon dots ameliorates dextran sodium sulphate-induced ulcerative colitis in mice
Author: Zhang, Yifan; Zhao, Jie; Zhao, Yusheng; Bai, Xue; Chen, Yumin; Liu, Yuhan; Zhang, Yue; Kong, Hui; Qu, Huihua; Zhao, Yan

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 180-191. DOI: 10.1080/21691401.2023.2197947
2、a-Lipoic acid loaded hollow gold nanoparticles designed for osteoporosis treatment: preparation, characterization and in vitro evaluation
Author: Xi, Yanhai; Pan, Wenming; Liu, Yanyan; Liu, Ji; Xu, Guohua; Su, Yanguo; Chen, Daquan; Ye, Xiaojian

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 131-138. DOI: 10.1080/21691401.2022.2149542
3、Simple and feasible detection of hepatitis a virus using reverse transcription multienzyme isothermal rapid amplification and lateral flow dipsticks without standard PCR laboratory
Author: Sun, Mao-ling; Zhong, Yang; Li, Xiao-na; Yao, Jun; Pan, Yu-qing

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 233-240. DOI: 10.1080/21691401.2023.2203198
4、Identification of stemness subtypes and features to improve endometrial cancer treatment using machine learning
Author: Lu, Xiaoqin; Ying, Yanqi; Zhang, Wenyi; Li, Rui; Wang, Wuliang

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 57-73. DOI: 10.1080/21691401.2023.2172027
5、PEG-conjugated bovine haemoglobin enhances efficiency of chemotherapeutic agent doxorubicin with alleviating DOX-induced splenocardiac toxicity in the breast cancer
Author: Li, Bingting; Zhang, Jun; Ma, Ning; Li, Weidan; You, Guoxing; Chen, Gan; Zhao, Lian; Wang, Quan; Zhou, Hong

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 120-130. DOI: 10.1080/21691401.2023.2176865
6、Novel dual CAFs and tumour cell targeting pH and ROS dual sensitive micelles for targeting delivery of paclitaxel to liver cancer
Author: Guo, Chunjing; Zhang, Wei; Zhang, Qiaoyun; Su, Yanguo; Hou, Xiaoya; Chen, Qiang; Guo, Huimin; Kong, Ming; Chen, Daquan

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 170-179. DOI: 10.1080/21691401.2023.2193221
7、Exploration of effective biomarkers and infiltrating Immune cells in Osteoarthritis based on bioinformatics analysis
Author: Cheng, Piaotao; Gong, Shouhang; Guo, Caopei; Kong, Ping; Li, Chencheng; Yang, Chengbing; Zhang, Tao; Peng, Jiachen

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 242-254. DOI: 10.1080/21691401.2023.2185627
8、A novel PDT: 5-aminolevulinic acid combined 450 nm blue laser photodynamic therapy significantly promotes cell death of HR-HPV infected cells
Author: Chen, Yuqing; Mei, Yibo; Gu, Lijiang; Li, Xing; Guo, Peng; Chen, Lihong; He, Dalin

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 22-32. DOI: 10.1080/21691401.2022.2164585